Impaired H3K36 methylation defines a subset of head and neck squamous cell carcinomas

Nature Genetics

Volumn 49, Issue 2, 2017, Pages 180-185

  Papillon Cavanagh, Simon ^a   Lu, Chao ^b   Gayden, Tenzin ^a   Mikael, Leonie G ^c   Bechet, Denise ^a   Karamboulas, Christina ^d   Ailles, Laurie ^d   Karamchandani, Jason ^e   Marchione, Dylan M ^f   Garcia, Benjamin A ^f   Weinreb, Ilan ^g   Goldstein, David ^d   Lewis, Peter W ^h   Dancu, Octavia Maria ^a   Dhaliwal, Sandeep ⁱ   Stecho, William ⁱ   Howlett, Christopher J ⁱ   Mymryk, Joe S ^i,j   Barrett, John W ^i,j   Nichols, Anthony C ^i,j   Allis, C David ^b   Majewski, Jacek ^a   Jabado, Nada ^a,c   more..

^a MCGILL UNIVERSITY   (Canada)

^b ROCKEFELLER UNIVERSITY   (United States)

^c RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^d PRINCESS MARGARET HOSPITAL   (Canada)

^e MCGILL UNIVERSITY   (Canada)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

^g UNIVERSITY HEALTH NETWORK   (Canada)

^h UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

ⁱ UNIVERSITY OF WESTERN ONTARIO   (Canada)

^j LAWSON HEALTH RESEARCH INSTITUTE   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; HISTONE H3; HISTONE H3K36; NOTCH1 RECEPTOR; POLYSORBATE 20; PROTEIN; PROTEIN NSD1; PROTEIN P53; PROTEIN PI3KCA; UNCLASSIFIED DRUG; HISTONE; NSD1 PROTEIN, HUMAN; NUCLEAR PROTEIN; SIGNAL PEPTIDE;

ARTICLE; CARCINOGENESIS; CELL DIFFERENTIATION; CHROMOSOME DELETION; CONTROLLED STUDY; DNA METHYLATION; GENE EXPRESSION; GENE MUTATION; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HISTONE METHYLATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RNA SEQUENCE; WART VIRUS; GENETIC EPIGENESIS; GENETICS; HEAD AND NECK TUMOR; MUTATION; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTION; PATHOGENICITY; SQUAMOUS CELL CARCINOMA;

CARCINOGENESIS; CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; DNA METHYLATION; EPIGENESIS, GENETIC; HEAD AND NECK NEOPLASMS; HISTONES; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MUTATION; NUCLEAR PROTEINS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS;

EID: 85008661446     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng.3757     Document Type: Article

References (100)

1. Gillison, M.L., et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J. Natl. Cancer Inst. 92, 709-720 (2000).
2. Ferlay, J., et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int. J. Cancer 127, 2893-2917 (2010).
3. Baxi, S., Fury, M., Ganly, I., Rao, S., Pfister, D.G. Ten years of progress in head and neck cancers. J. Natl. Compr. Canc. Netw. 10, 806-810 (2012).
4. Agrawal, N., et al. Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science 333, 1154-1157 (2011).
5. Stransky, N., et al. The mutational landscape of head and neck squamous cell carcinoma. Science 333, 1157-1160 (2011).
6. Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature 517, 576-582 (2015).
7. Ang, K.K., et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N. Engl. J. Med. 363, 24-35 (2010).
8. Sun, W., Califano, J.A. Sequencing the head and neck cancer genome: implications for therapy. Ann. NY Acad. Sci. 1333, 33-42 (2014).
9. Gaykalova, D.A., et al. Novel insight into mutational landscape of head and neck squamous cell carcinoma. PLoS One 9, e93102 (2014).
10. Hedberg, M.L., et al. Genetic landscape of metastatic and recurrent head and neck squamous cell carcinoma. J. Clin. Invest. 126, 1606 (2016).
11. Pickering, C.R., et al. Integrative genomic characterization of oral squamous cell carcinoma identifies frequent somatic drivers. Cancer Discov. 3, 770-781 (2013).
12. Seiwert, T.Y., et al. Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas. Clin. Cancer Res. 21, 632-641 (2015).
13. Hammerman, P.S., Hayes, D.N., Grandis, J.R. Therapeutic insights from genomic studies of head and neck squamous cell carcinomas. Cancer Discov. 5, 239-244 (2015).
14. Wagner, E.J., Carpenter, P.B. Understanding the language of Lys36 methylation at histone H3. Nat. Rev. Mol. Cell Biol. 13, 115-126 (2012).
15. Fontebasso, A.M., et al. Mutations in SETD2 and genes affecting histone H3K36 methylation target hemispheric high-grade gliomas. Acta Neuropathol. 125, 659-669 (2013).
16. Wang, G.G., Cai, L., Pasillas, M.P., Kamps, M.P. NUP98-NSD1 links H3K36 methylation to Hox-A gene activation and leukaemogenesis. Nat. Cell Biol. 9, 804-812 (2007).
17. Behjati, S., et al. Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone. Nat. Genet. 45, 1479-1482 (2013).
18. Jaffe, J.D., et al. Global chromatin profiling reveals NSD2 mutations in pediatric acute lymphoblastic leukemia. Nat. Genet. 45, 1386-1391 (2013).
19. Dalgliesh, G.L., et al. Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes. Nature 463, 360-363 (2010).
20. Schwartzentruber, J., et al. Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature 482, 226-231 (2012).
21. Douglas, J., et al. NSD1 mutations are the major cause of Sotos syndrome and occur in some cases of Weaver syndrome but are rare in other overgrowth phenotypes. Am. J. Hum. Genet. 72, 132-143 (2003).
22. Tonon, G., et al. High-resolution genomic profiles of human lung cancer. Proc. Natl. Acad. Sci. USA 102, 9625-9630 (2005).
23. Zhang, J., et al. The genetic basis of early T-cell precursor acute lymphoblastic leukaemia. Nature 481, 157-163 (2012).
24. Reva, B., Antipin, Y., Sander, C. Predicting the functional impact of protein mutations: application to cancer genomics. Nucleic Acids Res. 39, e118 (2011).
25. Qiao, Q., et al. The structure of NSD1 reveals an autoregulatory mechanism underlying histone H3K36 methylation. J. Biol. Chem. 286, 8361-8368 (2011).
26. Sun, W., et al. Activation of the NOTCH pathway in head and neck cancer. Cancer Res. 74, 1091-1104 (2014).
27. Hayes, D.N., Van Waes, C., Seiwert, T.Y. Genetic landscape of human papillomavirus-associated head and neck cancer and comparison to tobacco-related tumors. J. Clin. Oncol. 33, 3227-3234 (2015).
28. Vokes, E.E., Agrawal, N., Seiwert, T.Y. HPV-associated head and neck cancer. J. Natl. Cancer Inst. 107, djv344 (2015).
29. India Project Team of the International Cancer Genome Consortium. Mutational landscape of gingivo-buccal oral squamous cell carcinoma reveals new recurrently-mutated genes and molecular subgroups. Nat. Commun. 4, 2873 (2013).
30. Pickering, C.R., et al. Mutational landscape of aggressive cutaneous squamous cell carcinoma. Clin. Cancer Res. 20, 6582-6592 (2014).
31. Lewis, P.W., et al. Inhibition of PRC2 activity by a gain-of-function H3 mutation found in pediatric glioblastoma. Science 340, 857-861 (2013).
32. Lu, C., et al. Histone H3K36 mutations promote sarcomagenesis through altered histone methylation landscape. Science 352, 844-849 (2016).
33. Walter, V., et al. Molecular subtypes in head and neck cancer exhibit distinct patterns of chromosomal gain and loss of canonical cancer genes. PLoS One 8, e56823 (2013).
34. De Cecco, L., et al. Head and neck cancer subtypes with biological and clinical relevance: meta-analysis of gene-expression data. Oncotarget 6, 9627-9642 (2015).
35. Saloura, V., et al. WHSC1 promotes oncogenesis through regulation of NIMA-related kinase-7 in squamous cell carcinoma of the head and neck. Mol. Cancer Res. 13, 293-304 (2015).
36. Choufani, S., et al. NSD1 mutations generate a genome-wide DNA methylation signature. Nat. Commun. 6, 10207 (2015).
37. Dhayalan, A., et al. The Dnmt3a PWWP domain reads histone 3 lysine 36 trimethylation and guides DNA methylation. J. Biol. Chem. 285, 26114-26120 (2010).
38. Baubec, T., et al. Genomic profiling of DNA methyltransferases reveals a role for DNMT3B in genic methylation. Nature 520, 243-247 (2015).
39. Johnson, B.E., et al. Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma. Science 343, 189-193 (2014).
40. Nikbakht, H., et al. Spatial and temporal homogeneity of driver mutations in diffuse intrinsic pontine glioma. Nat. Commun. 7, 11185 (2016).
41. Aryee, M.J., et al. Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays. Bioinformatics 30, 1363-1369 (2014).
42. Wang, K., Li, M., Hakonarson, H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 38, e164 (2010).
43. Liao, Y., Smyth, G.K., Shi, W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30, 923-930 (2014).
44. Love, M.I., Huber, W., Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).
45. Nii, M., Kayada, Y., Yoshiga, K., Takada, K., Yanagihara, K. Expression of type IV collagen-degrading metalloproteinases and tissue inhibitors of metalloproteinases in newly established human oral malignant tumor lines. Jpn. J. Clin. Oncol. 26, 117-123 (1996).
46. Heo, D.S., et al. Biology, cytogenetics, and sensitivity to immunological effector cells of new head and neck squamous cell carcinoma lines. Cancer Res. 49, 5167-5175 (1989).
47. Zietman, A.L., Suit, H.D., Ramsay, J.R., Silobrcic, V., Sedlacek, R.S. Quantitative studies on the transplantability of murine and human tumors into the brain and subcutaneous tissues of NCr/Sed nude mice. Cancer Res. 48, 6510-6516 (1988).
48. Rheinwald, J.G., Beckett, M.A. Tumorigenic keratinocyte lines requiring anchorage and fibroblast support cultured from human squamous cell carcinomas. Cancer Res. 41, 1657-1663 (1981).
49. Sidoli, S., Bhanu, N.V., Karch, K.R., Wang, X., Garcia, B.A. Complete workflow for analysis of histone post-translational modifications using bottom-up mass spectrometry: from histone extraction to data analysis. J. Vis. Exp. http://dx.doi.org/10.3791/54112 (2016).
50. Sidoli, S., Simithy, J., Karch, K.R., Kulej, K., Garcia, B.A. Low resolution data-independent acquisition in an LTQ-Orbitrap allows for simplified and fully untargeted analysis of histone modifications. Anal. Chem. 87, 11448-11454 (2015).
51. Gillison, M.L., et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J. Natl. Cancer Inst. 92, 709-720 (2000).
52. Ferlay, J., et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int. J. Cancer 127, 2893-2917 (2010).
53. Baxi, S., Fury, M., Ganly, I., Rao, S., Pfister, D.G. Ten years of progress in head and neck cancers. J. Natl. Compr. Canc. Netw. 10, 806-810 (2012).
54. Agrawal, N., et al. Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science 333, 1154-1157 (2011).
55. Stransky, N., et al. The mutational landscape of head and neck squamous cell carcinoma. Science 333, 1157-1160 (2011).
56. Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature 517, 576-582 (2015).
57. Ang, K.K., et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N. Engl. J. Med. 363, 24-35 (2010).
58. Sun, W., Califano, J.A. Sequencing the head and neck cancer genome: implications for therapy. Ann. NY Acad. Sci. 1333, 33-42 (2014).
59. Gaykalova, D.A., et al. Novel insight into mutational landscape of head and neck squamous cell carcinoma. PLoS One 9, e93102 (2014).
60. Hedberg, M.L., et al. Genetic landscape of metastatic and recurrent head and neck squamous cell carcinoma. J. Clin. Invest. 126, 1606 (2016).
61. Pickering, C.R., et al. Integrative genomic characterization of oral squamous cell carcinoma identifies frequent somatic drivers. Cancer Discov. 3, 770-781 (2013).
62. Seiwert, T.Y., et al. Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas. Clin. Cancer Res. 21, 632-641 (2015).
63. Hammerman, P.S., Hayes, D.N., Grandis, J.R. Therapeutic insights from genomic studies of head and neck squamous cell carcinomas. Cancer Discov. 5, 239-244 (2015).
64. Wagner, E.J., Carpenter, P.B. Understanding the language of Lys36 methylation at histone H3. Nat. Rev. Mol. Cell Biol. 13, 115-126 (2012).
65. Fontebasso, A.M., et al. Mutations in SETD2 and genes affecting histone H3K36 methylation target hemispheric high-grade gliomas. Acta Neuropathol. 125, 659-669 (2013).
66. Wang, G.G., Cai, L., Pasillas, M.P., Kamps, M.P. NUP98-NSD1 links H3K36 methylation to Hox-A gene activation and leukaemogenesis. Nat. Cell Biol. 9, 804-812 (2007).
67. Behjati, S., et al. Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone. Nat. Genet. 45, 1479-1482 (2013).
68. Jaffe, J.D., et al. Global chromatin profiling reveals NSD2 mutations in pediatric acute lymphoblastic leukemia. Nat. Genet. 45, 1386-1391 (2013).
69. Dalgliesh, G.L., et al. Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes. Nature 463, 360-363 (2010).
70. Schwartzentruber, J., et al. Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature 482, 226-231 (2012).
71. Douglas, J., et al. NSD1 mutations are the major cause of Sotos syndrome and occur in some cases of Weaver syndrome but are rare in other overgrowth phenotypes. Am. J. Hum. Genet. 72, 132-143 (2003).
72. Tonon, G., et al. High-resolution genomic profiles of human lung cancer. Proc. Natl. Acad. Sci. USA 102, 9625-9630 (2005).
73. Zhang, J., et al. The genetic basis of early T-cell precursor acute lymphoblastic leukaemia. Nature 481, 157-163 (2012).
74. Reva, B., Antipin, Y., Sander, C. Predicting the functional impact of protein mutations: application to cancer genomics. Nucleic Acids Res. 39, e118 (2011).
75. Qiao, Q., et al. The structure of NSD1 reveals an autoregulatory mechanism underlying histone H3K36 methylation. J. Biol. Chem. 286, 8361-8368 (2011).
76. Sun, W., et al. Activation of the NOTCH pathway in head and neck cancer. Cancer Res. 74, 1091-1104 (2014).
77. Hayes, D.N., Van Waes, C., Seiwert, T.Y. Genetic landscape of human papillomavirus-associated head and neck cancer and comparison to tobacco-related tumors. J. Clin. Oncol. 33, 3227-3234 (2015).
78. Vokes, E.E., Agrawal, N., Seiwert, T.Y. HPV-associated head and neck cancer. J. Natl. Cancer Inst. 107, djv344 (2015).
79. India Project Team of the International Cancer Genome Consortium. Mutational landscape of gingivo-buccal oral squamous cell carcinoma reveals new recurrently-mutated genes and molecular subgroups. Nat. Commun. 4, 2873 (2013).
80. Pickering, C.R., et al. Mutational landscape of aggressive cutaneous squamous cell carcinoma. Clin. Cancer Res. 20, 6582-6592 (2014).
81. Lewis, P.W., et al. Inhibition of PRC2 activity by a gain-of-function H3 mutation found in pediatric glioblastoma. Science 340, 857-861 (2013).
82. Lu, C., et al. Histone H3K36 mutations promote sarcomagenesis through altered histone methylation landscape. Science 352, 844-849 (2016).
83. Walter, V., et al. Molecular subtypes in head and neck cancer exhibit distinct patterns of chromosomal gain and loss of canonical cancer genes. PLoS One 8, e56823 (2013).
84. De Cecco, L., et al. Head and neck cancer subtypes with biological and clinical relevance: meta-analysis of gene-expression data. Oncotarget 6, 9627-9642 (2015).
85. Saloura, V., et al. WHSC1 promotes oncogenesis through regulation of NIMA-related kinase-7 in squamous cell carcinoma of the head and neck. Mol. Cancer Res. 13, 293-304 (2015).
86. Choufani, S., et al. NSD1 mutations generate a genome-wide DNA methylation signature. Nat. Commun. 6, 10207 (2015).
87. Dhayalan, A., et al. The Dnmt3a PWWP domain reads histone 3 lysine 36 trimethylation and guides DNA methylation. J. Biol. Chem. 285, 26114-26120 (2010).
88. Baubec, T., et al. Genomic profiling of DNA methyltransferases reveals a role for DNMT3B in genic methylation. Nature 520, 243-247 (2015).
89. Johnson, B.E., et al. Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma. Science 343, 189-193 (2014).
90. Nikbakht, H., et al. Spatial and temporal homogeneity of driver mutations in diffuse intrinsic pontine glioma. Nat. Commun. 7, 11185 (2016).
91. Aryee, M.J., et al. Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays. Bioinformatics 30, 1363-1369 (2014).
92. Wang, K., Li, M., Hakonarson, H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 38, e164 (2010).
93. Liao, Y., Smyth, G.K., Shi, W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30, 923-930 (2014).
94. Love, M.I., Huber, W., Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).
95. Nii, M., Kayada, Y., Yoshiga, K., Takada, K., Yanagihara, K. Expression of type IV collagen-degrading metalloproteinases and tissue inhibitors of metalloproteinases in newly established human oral malignant tumor lines. Jpn. J. Clin. Oncol. 26, 117-123 (1996).
96. Heo, D.S., et al. Biology, cytogenetics, and sensitivity to immunological effector cells of new head and neck squamous cell carcinoma lines. Cancer Res. 49, 5167-5175 (1989).
97. Zietman, A.L., Suit, H.D., Ramsay, J.R., Silobrcic, V., Sedlacek, R.S. Quantitative studies on the transplantability of murine and human tumors into the brain and subcutaneous tissues of NCr/Sed nude mice. Cancer Res. 48, 6510-6516 (1988).
98. Rheinwald, J.G., Beckett, M.A. Tumorigenic keratinocyte lines requiring anchorage and fibroblast support cultured from human squamous cell carcinomas. Cancer Res. 41, 1657-1663 (1981).
99. Sidoli, S., Bhanu, N.V., Karch, K.R., Wang, X., Garcia, B.A. Complete workflow for analysis of histone post-translational modifications using bottom-up mass spectrometry: from histone extraction to data analysis. J. Vis. Exp. http://dx.doi.org/10.3791/54112 (2016).
100. Sidoli, S., Simithy, J., Karch, K.R., Kulej, K., Garcia, B.A. Low resolution data-independent acquisition in an LTQ-Orbitrap allows for simplified and fully untargeted analysis of histone modifications. Anal. Chem. 87, 11448-11454 (2015).